Less is more:patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapiesOA
Less is more:patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies
Bohao Zheng;Dian Fan;Shengtao Zhou
Department of Obstetrics and Gynecology,Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education and State Key Laboratory of Biotherapy,West China Second Hospital,Sichuan University and Collaborative Innovation Center,Chengdu 610000,China||Wuxi School of Medicine,Jiangnan University,Wuxi 214000,ChinaDepartment of Obstetrics and Gynecology,Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education and State Key Laboratory of Biotherapy,West China Second Hospital,Sichuan University and Collaborative Innovation Center,Chengdu 610000,ChinaDepartment of Obstetrics and Gynecology,Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education and State Key Laboratory of Biotherapy,West China Second Hospital,Sichuan University and Collaborative Innovation Center,Chengdu 610000,China
《癌症生物学与医学(英文版)》 2026 (8)
1051-1056,6
评论